Springer Nature OAopen access
Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C–mutant non-small cell lung cancer
Medicine & Public Health, Medicine/Public Health, general, Internal Medicine, Cell Biology, Human Genetics, Oncology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 406912
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.